Hydragel 7 Lipoprotein(E), PN 4114 & Hydragel Lipoprotein(E) 15/30 PN 4134
FDA 510(k) K022053 · Sebia
510(k) numberK022053
Submission
- Device name
- Hydragel 7 Lipoprotein(E), PN 4114 & Hydragel Lipoprotein(E) 15/30 PN 4134
- Applicant
- Sebia
Chelsea, MI, US - Received
- June 24, 2002
- Decision date
- July 12, 2002
- Decision
- Substantially Equivalent (SESE)
- Type
- Special 510(k)
- Summary
- 510(k) statement available from FDA
Device classification
- Product code
- JHO – Electrophoretic Separation, Lipoproteins
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 862.1475
- Specialty
- Clinical Chemistry
Other 510(k)s with product code JHO
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K022333 | Spife LIPPOROTEIN-12, Model 3344JHO · Traditional | Helena Laboratories | 08/15/2002SE |
| K013662 | Modification to Lipoprint System, LDL SubfractionsJHO · Special | Quantimetrix Corp. | 03/08/2002SE |
| K012789 | Modified to Ldl/Hdl Chol Direct Kit-P.N. 4005, 4103,4123JHO · Special | Morax | 01/17/2002SE |
| K013466 | Spife 2000/3000 Lipoprotein; Model# 3340, 3341, 3342, 3343JHO · Traditional | Helena Laboratories | 12/21/2001SE |
| K010337 | Lipoprint System, LDL SubfractionsJHO · Traditional | Quantimetrix Corp. | 07/25/2001SE |
| K000603 | Spife Cholesterol Profile KitJHO · Traditional | Helena Laboratories | 04/17/2000SE |
| K992971 | Rep Cholesterol Profile KitJHO · Traditional | Helena Laboratories | 10/18/1999SE |
| K974854 | Hydragel-Mini Lipo Kit-Pn 4093, Hydragel Lipo Kit-Pn 4007, Hydragel Lipo Maxi Kit-Pn 4207JHO · Traditional | Morax | 10/07/1998SE |
| K980650 | Rep Cholesterol Profile TEMPLATE-30, -16, -8; Rep Vis CholesterolJHO · Traditional | Helena Laboratories | 05/01/1998SE |
| K971157 | Macralp(A) Enzyme Immunoassay KitJHO · Traditional | Strategic Diagnostics, Inc. | 04/15/1998SE |
More from Strategic Diagnostics, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K232027 | CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS InstrumentGKA · Traditional | 04/04/2024SE |
| K231601 | FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2DFH · Traditional | 02/23/2024SE |
| K210623 | FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2DFH · Traditional | 11/18/2022SE |
| K203184 | HYDRASHIFT 2/4 isatuximabCFF · Traditional | 11/12/2021SE |
| K192095 | CAPI 3 Immunotyping, Capillarys 3 TeraCFF · Traditional | 11/01/2019SE |
| K190851 | HYDRASHIFT 2/4 daratumumabCFF · Special | 05/02/2019SE |
| K180762 | Capi 3 Hemoglobin(E)GKA · Traditional | 12/14/2018SE |
| K171861 | CAPILLARYS Hb A1cPDJ · Traditional | 02/07/2018SE |
| K172195 | HYDRASHIFT 2/4 daratumumab, daratumumab ControlCFF · Traditional | 01/11/2018SE |
| K171537 | CAPI 3 Hb A1cPDJ · Traditional | 09/12/2017SE |
Questions and answers
When was Hydragel 7 Lipoprotein(E), PN 4114 & Hydragel Lipoprotein(E) 15/30 PN 4134 cleared by the FDA?
Hydragel 7 Lipoprotein(E), PN 4114 & Hydragel Lipoprotein(E) 15/30 PN 4134 (K022053) received a 510(k) decision of Substantially Equivalent on July 12, 2002, 18 days after the submission was received.
What is the product code of K022053?
The FDA product code is JHO – Electrophoretic Separation, Lipoproteins, a Class I (low risk) device regulated under 21 CFR 862.1475.